161 related articles for article (PubMed ID: 17017890)
1. Phenothiazines and structurally related compounds as modulators of cancer multidrug resistance.
Tsakovska I; Pajeva I
Curr Drug Targets; 2006 Sep; 7(9):1123-34. PubMed ID: 17017890
[TBL] [Abstract][Full Text] [Related]
2. Interactions of phenothiazines with lipid bilayer and their role in multidrug resistance reversal.
Michalak K; Wesolowska O; Motohashi N; Molnar J; Hendrich AB
Curr Drug Targets; 2006 Sep; 7(9):1095-105. PubMed ID: 17017888
[TBL] [Abstract][Full Text] [Related]
3. QSAR and 3D-QSAR of phenothiazine type multidrug resistance modulators in P388/ADR cells.
Tsakovska IM
Bioorg Med Chem; 2003 Jul; 11(13):2889-99. PubMed ID: 12788359
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biochemical characterization of new phenothiazines and related drugs as MDR reversal agents.
Schmidt M; Teitge M; Castillo ME; Brandt T; Dobner B; Langner A
Arch Pharm (Weinheim); 2008 Oct; 341(10):624-38. PubMed ID: 18816589
[TBL] [Abstract][Full Text] [Related]
5. Interaction of phenothiazines, stilbenes and flavonoids with multidrug resistance-associated transporters, P-glycoprotein and MRP1.
Wesołowska O
Acta Biochim Pol; 2011; 58(4):433-48. PubMed ID: 22187677
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic and multidrug resistance reversal activity of phenothiazine derivative is strongly enhanced by theobromine, a phytochemical from cocoa.
Środa-Pomianek K; Michalak K; Palko-Łabuz A; Poła A; Dzięgiel P; Puła B; Świątek P; Wesołowska O
Eur J Pharmacol; 2019 Apr; 849():124-134. PubMed ID: 30721703
[TBL] [Abstract][Full Text] [Related]
7. Structural features determining activity of phenothiazines and related drugs for inhibition of cell growth and reversal of multidrug resistance.
Ford JM; Prozialeck WC; Hait WN
Mol Pharmacol; 1989 Jan; 35(1):105-15. PubMed ID: 2563302
[TBL] [Abstract][Full Text] [Related]
8. Reversal of ABCB1-related Multidrug Resistance of Colonic Adenocarcinoma Cells by Phenothiazines.
Takács D; Csonka Á; Horváth Á; Windt T; Gajdács M; Riedl Z; Hajós G; Amaral L; Molnár J; Spengler G
Anticancer Res; 2015 Jun; 35(6):3245-51. PubMed ID: 26026084
[TBL] [Abstract][Full Text] [Related]
9. The Combined Use of Phenothiazines and Statins Strongly Affects Doxorubicin-Resistance, Apoptosis, and Cox-2 Activity in Colon Cancer Cells.
Środa-Pomianek K; Michalak K; Palko-Łabuz A; Uryga A; Świątek P; Majkowski M; Wesołowska O
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30813251
[TBL] [Abstract][Full Text] [Related]
10. Phenothiazines and Selenocompounds: A Potential Novel Combination Therapy of Multidrug Resistant Cancer.
GajdÁcs M; NovÉ M; Csonka Á; Varga B; SanmartÍn C; DomÍnguez-Álvarez E; Spengler G
Anticancer Res; 2020 Sep; 40(9):4921-4928. PubMed ID: 32878780
[TBL] [Abstract][Full Text] [Related]
11. New phenothiazine-type multidrug resistance modifiers: anti-MDR activity versus membrane perturbing potency.
Hendrich AB; Wesołowska O; Motohashi N; Molnár J; Michalak K
Biochem Biophys Res Commun; 2003 May; 304(2):260-5. PubMed ID: 12711308
[TBL] [Abstract][Full Text] [Related]
12. Reversal of multidrug resistance by phenothiazines and structurally related compounds.
Ramu A; Ramu N
Cancer Chemother Pharmacol; 1992; 30(3):165-73. PubMed ID: 1628364
[TBL] [Abstract][Full Text] [Related]
13. Preliminary studies on phenothiazine-mediated reversal of multidrug resistance in mouse lymphoma and COLO 320 cells.
Pajak B; Molnar J; Engi H; Orzechowski A
In Vivo; 2005; 19(6):1101-4. PubMed ID: 16277030
[TBL] [Abstract][Full Text] [Related]
14. Quinolizidinyl derivatives of iminodibenzyl and phenothiazine as multidrug resistance modulators in ovarian cancer cells.
Barbieri F; Alama A; Tasso B; Boido V; Bruzzo C; Sparatore F
Invest New Drugs; 2003 Nov; 21(4):413-20. PubMed ID: 14586208
[TBL] [Abstract][Full Text] [Related]
15. Multidrug resistance reversing activity of newly developed phenothiazines on P-glycoprotein (ABCB1)-related resistance of mouse T-lymphoma cells.
Spengler G; Takács D; Horváth A; Riedl Z; Hajós G; Amaral L; Molnár J
Anticancer Res; 2014 Apr; 34(4):1737-41. PubMed ID: 24692704
[TBL] [Abstract][Full Text] [Related]
16. Reversal of multidrug resistance in mouse lymphoma cells by phenothiazines.
Molnar J; Molnar A; Mucsi I; Pinter O; Nagy B; Varga A; Motohashi N
In Vivo; 2003; 17(2):145-9. PubMed ID: 12792975
[TBL] [Abstract][Full Text] [Related]
17. Multidrug resistance reverting activity and antitumor profile of new phenothiazine derivatives.
Bisi A; Meli M; Gobbi S; Rampa A; Tolomeo M; Dusonchet L
Bioorg Med Chem; 2008 Jul; 16(13):6474-82. PubMed ID: 18522868
[TBL] [Abstract][Full Text] [Related]
18. Understanding of human ATP binding cassette superfamily and novel multidrug resistance modulators to overcome MDR.
Mohammad IS; He W; Yin L
Biomed Pharmacother; 2018 Apr; 100():335-348. PubMed ID: 29453043
[TBL] [Abstract][Full Text] [Related]
19. 3D QSAR investigation of the blood-brain barrier penetration of chemical compounds.
Lessigiarska I; Pajeva I; Cronin MT; Worth AP
SAR QSAR Environ Res; 2005; 16(1-2):79-91. PubMed ID: 15844444
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationships of multidrug resistance reversers.
Wiese M; Pajeva IK
Curr Med Chem; 2001 May; 8(6):685-713. PubMed ID: 11281849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
